HHS Syndication Storefront

The HHS Syndication Storefront allows you to syndicate (import) content from many HHS websites directly into your own website or application. These services are provided by HHS free of charge.

Search Media Items


Filter results by:
spinner

Newest Syndicated Content

NCI

Aiming to Prevent Hereditary Cancers, Researchers Focus on Lynch Syndrome

An NCI research update article about a workshop to discuss new strategies for preventing hereditary cancers by using Lynch syndrome as a model.

Preview   0 Users liked this content.
NCI

ALCHEMIST <span style="font-weight:normal"><i>(The Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials)</i></span>: Questions and Answers

treatment  trial  drug  screening  lung  tumor  genetic  childhood acute lymphoblastic leukemia  T-cell childhood acute lymphoblastic leukemia  Philadelphia chromosome-positive childhood acute lymphoblastic leukemia  gene  marker  mutation  ALK  EGFR  survival  ALCHEMIST 

ALCHEMIST represents three integrated, precision medicine trials that are designed to identify people with early-stage lung cancer who have tumors that harbor certain uncommon genetic changes and evaluate whether drug treatments targeted against those mol

Preview   0 Users liked this content.
NCI

Estudios clínicos de cáncer en el Centro Clínico de los Institutos Nacionales de la Salud

nih  non-small cell lung cancer  Tratamiento  estudios  investigación  segunda opinión  consentimiento formal  1.22  Magnuson  Hatfield  CCR  clinicos  centro  criterios de elegibilidad 

Información acerca de los estudios clínicos de cáncer en el Centro Clínico de NIH en Bethesda, Maryland.

Preview   0 Users liked this content.
NCI

Los cuidados al final de la vida de personas con cáncer

pancreatic cancer  apoyo  final de la vida  8.15s  anticipado  hogar  instrucciones  morir  muerte  psicosocial  terminal  testamento  vivir 

Hoja informativa que responde algunas de las preguntas que tienen muchos pacientes, sus familiares y quienes cuidan de ellos acerca del final de la vida.

Preview   0 Users liked this content.
NCI

In an Era of Precision Medicine, Testing New Approaches to Breast Cancer Screening

breast cancer 

An NCI research article about individualized approaches that could help identify those at risk of breast cancer who need to be screened and testing screening intervals that are appropriate for each person’s level of risk.

Preview   0 Users liked this content.
NCI

Questions to Ask Your Doctor about Your Diagnosis

Suggested questions for patients to ask their doctors when they learn they have cancer and want to know what to expect next.

Preview   0 Users liked this content.
NCI

Exceptional Responders Initiative: Questions and Answers

response  feature  therapy  drug  DNA  Colon Cancer  molecular  gene  responders  ERI  exceptional 

NCI has embarked on the Exceptional Responders Initiative to understand the molecular underpinnings of exceptional responses to treatment, primarily via chemotherapy, in cancer patients.

Preview   0 Users liked this content.
NCI

714-X (PDQ®)–Versión para profesionales de salud

adult Hodgkin lymphoma  714-X 

Resumen de información revisada por expertos sobre el uso del 714-X como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.

Preview   0 Users liked this content.
NCI

Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®)–Health Professional Version

prostate cancer  anal cancer  CAM nutritional therapy 

Nutrition methods and dietary supplements have been studied for prostate cancer prevention or treatment. Read about the history of research, laboratory, and human studies on various prostate supplements, such as calcium, green tea, lycopene, pomegranate, selenium, soy, and vitamin E in this expert-reviewed summary.

Preview   0 Users liked this content.
NCI

714-X (PDQ®)–Versión para pacientes

adjustment disorder  anxiety disorder  714-X 

Resumen de información revisada por expertos sobre el uso del 714-X como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.

Preview   0 Users liked this content.